These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1337219)

  • 1. The role of standard-dose etoposide in the management of non-small cell lung cancer.
    Ruckdeschel JC
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):39-44. PubMed ID: 1337219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with oral etoposide.
    Johnson DH; Hainsworth JD; Hande KR; Greco FA
    Semin Oncol; 1992 Dec; 19(6 Suppl 14):19-24. PubMed ID: 1336896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of small cell lung cancer].
    Ueoka H; Ohnoshi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic oral etoposide in the treatment of lung cancer.
    DeVore R; Hainsworth J; Greco FA; Hande K; Johnson D
    Semin Oncol; 1992 Dec; 19(6 Suppl 14):28-35. PubMed ID: 1336897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of oral etoposide in non-small cell lung cancer.
    Comis RL; Friedland DM; Good BC
    Drugs; 1999; 58 Suppl 3():21-30. PubMed ID: 10711838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.
    Rosell R; Felip E; Massuti B; González-Larriba JL; Benito D; López-Cabrerizo MP; Salamanca O; Camps C; Puerto-Pica J
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-56-S12-60. PubMed ID: 9331123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
    Planting A; Kho S; van der Burg M; Goey H; Schellens J; van den Bent M; van der Gaast A; de Boer-Dennert M; Stoter G; Verweij J
    Cancer Chemother Pharmacol; 1997; 40(4):347-52. PubMed ID: 9225954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum/oral etoposide therapy in non-small cell lung cancer.
    Furuse K
    Oncology; 1992; 49 Suppl 1():63-9; discussion 70. PubMed ID: 1323814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
    Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
    Anticancer Res; 1997; 17(6D):4755-8. PubMed ID: 9494602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.
    Felip E; Massuti B; Camps C; Benito D; Isla D; González-Larriba JL; López-Cabrerizo MP; Salamanca O; Puerto-Pica J; Moyano A; Baselga J; Rosell R
    Clin Cancer Res; 1998 Nov; 4(11):2723-8. PubMed ID: 9829735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin/etoposide in small cell lung cancer.
    Bishop JF
    Oncology; 1992; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide: current status and future perspectives in the management of malignant neoplasms.
    Belani CP; Doyle LA; Aisner J
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S118-26. PubMed ID: 8070020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic oral etoposide: trials at Indiana University and with the Hoosier Oncology Group.
    Loehrer PJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 14):48-52. PubMed ID: 1336900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent changes in the management of advanced non-small cell lung cancer].
    Kodama N; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer.
    Palackdharry CS; Krigel RL
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):6-11. PubMed ID: 8209278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged administration of low-daily-dose etoposide: a superior dosing schedule?
    Greco FA; Hainsworth JD
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S101-4. PubMed ID: 8070017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
    Kinoshita T; Akaogi E; Mitsui K; Onizuka M; Ishikawa S; Morita R; Ishibashi O; Suga M; Inagaki M; Okazaki H
    Gan To Kagaku Ryoho; 1994 May; 21(6):891-4. PubMed ID: 8185351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etoposide in the treatment of small-cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
    Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.